Upadacitinib
Thông số
1310726-60-3Số CAS
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamideTên IUPAC
C17H19F3N6OCông thức hóa học
380.4 g/molKhối lượng phân tử
Upadacitinib; 1310726-60-3; ABT-494; Upadacitinib anhydrous; 4RA0KN46E0; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; DTXSID901027919; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; upadacitinibum; RefChem:57163; L04AA44; DTXCID401513480; (3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; Rinvoq; (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; ABT 494; UNII-4RA0KN46E0; C17H19F3N6O; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-; Upadacitinib [USAN]; Upadacitinib (Standard); UPADACITINIB [MI]; Upadacitinib, ABT-494; Upadacitinib (USAN/INN); UPADACITINIB [INN]; Upadacitinib [USAN:INN]; Upadacitinib (ABT-494); UPADACITINIB [WHO-DD]; GTPL9246; orb1299762; SCHEMBL9991056; CHEMBL3622821; WYQFJHHDOKWSHR-MNOVXSKESA-N; GLXC-10425; UPADACITINIB [ORANGE BOOK]; EX-A1628; BDBM50503287; EBC-26865; HY-19569R; s8162; AKOS030567686; CS-6150; DB15091; ABBV-599 COMPONENT UPADACITINIB; NCGC00588874-01; AC-30326; AS-56379; DA-78788; FA166721; HY-19569; NS00133778; T7503; C72237; D10994; F797290; Q27074125; Z2831495606; (3S,4R)-3- Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; (3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide; 1831899-72-9; ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; rel-(3R,4S)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamideTên gọi khác
Sản phẩm chứa Upadacitinib
CHEMISTRY Discover Molecule InsightsUpadacitinib(Semihydrate)Upadacitinib TabletsUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUpadacitinibUPADACITINIB
Trang 1/3
Dịch vụ liên quan đến Upadacitinib
Công ty đang bán Upadacitinib
HR
Hangzhou Royall Import & Export Co.,LtdChinaJM
Jiangsu Magic Biotechnology Co., LtdChinaCP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaSI
Sinoway Industrial Co.Ltd.ChinaSI
Shanghai IntVal Chemicals Co., LtdChinaRG
ROUNDCARE GROUPChinaHH
HANGZHOU HONGQIN PHARMTECH CO.,LTDChinaSG
Sichuan Gowell Pharmaceutical Co., Ltd.ChinaAH
Anhui Haikang Pharmaceutical Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaTrang 1/2